{
  "ptid_time": "068_S_4332_2011-11-14",
  "img_path": "/data/qiuhui/data/adni/images/068_S_4332/2011-11-14/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 71,035 mm³, 136.6% above the reference mean. With a Z-score of 3.25 (99.9th percentile), this represents profound enlargement; hippocampal volume measures 7,004 mm³, 12.7% below the reference mean. With a Z-score of -1.27 (10.1th percentile), this represents mild atrophy; whole brain volume measures 1,342,720 mm³, 18.3% above the reference mean. With a Z-score of 2.60 (99.5th percentile), this represents significant enlargement; entorhinal cortex volume measures 4,574 mm³, 7.3% above the reference mean. With a Z-score of 0.51 (69.3th percentile), this represents normal volume ; fusiform gyrus volume measures 26,977 mm³, 35.5% above the reference mean. With a Z-score of 2.95 (99.8th percentile), this represents significant enlargement; middle temporal gyrus volume measures 28,682 mm³, 28.0% above the reference mean. With a Z-score of 2.30 (98.9th percentile), this represents significant enlargement. ",
  "text_data": "Age is 69.0 years. Gender is Male. Education: 14 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Hepatic; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking; Major Surgical Procedures. MMSE: 28.0. MoCA: 25.0. Logical Memory: 8.0. Laboratory findings: Eosinophils: 0.39 (significant elevated); Eosinophils: 6.10 (significant elevated); Creatine Kinase: 209.00 (significant elevated); GGT: 39.00 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.16 SUVR (normal ); Amyloid beta: 1531.00 pg/mL (mild elevated); Total tau: 233.70 pg/mL (normal ); Phosphorylated tau: 21.19 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The data shows profound ventricular enlargement and mild hippocampal atrophy, which are concerning for neurodegenerative changes. However, cognitive scores (MMSE 28, MoCA 25) remain within normal limits, and biomarker profiles (Aβ mildly elevated but T-tau/P-tau normal, AV45 normal) do not strongly support Alzheimer’s pathology.  \nDiagnosis: **MCI** (due to structural changes despite normal cognition, possibly early neurodegenerative process)  \nConfidence: **Medium** (conflicting findings—structural changes suggest risk, but biomarkers and cognition are not clearly aligned with dementia)",
  "timestamp": "2025-07-26T09:01:02.501950"
}